Multiple Congenital Anomalies-Hypotonia-Seizures Syndrome 2 via the PIGA Gene
Summary and Pricing
Test Method
Bi-Directional Sanger SequencingTest Code | Test Copy Genes | Test CPT Code | Gene CPT Codes Copy CPT Code | Base Price | |
---|---|---|---|---|---|
5761 | PIGA | 81479 | 81479 | $610 | Order Options and Pricing |
Pricing Comments
CNV detection may be ordered through Test #600.
An additional 25% charge will be applied to STAT orders. STAT orders are prioritized throughout the testing process.
Turnaround Time
4 weeks on average for standard orders or 2 weeks on average for STAT orders.
Please note: Once the testing process begins, an Estimated Report Date (ERD) range will be displayed in the portal. This is the most accurate prediction of when your report will be complete and may differ from the average TAT published on our website. About 85% of our tests will be reported within or before the ERD range. We will notify you of significant delays or holds which will impact the ERD. Learn more about turnaround times here.
Targeted Testing
For ordering sequencing of targeted known variants, go to our Targeted Variants page.
Clinical Features and Genetics
Clinical Features
Multiple congenital anomalies-hypotonia-seizures syndrome 2 is a rare neurodevelopmental disorder with onset in utero or early infancy. It may be lethal in infancy. The major features include dysmorphic features, neonatal hypotonia, myoclonic seizures, and variable congenital anomalies involving the central nervous, cardiac, and urinary systems (Johnston et al. 2012. PubMed ID: 22305531; Kato et al. 2014. PubMed ID: 24706016; Tarailo-Graovac et al. 2015. PubMed ID: 25885527).
Females with a heterozygous pathogenic variant in PIGA are normally unaffected. Somatic pathogenic variants in PIGA are considered to be causative for paroxysmal nocturnal hemoglobinuria (Johnston et al. 2012. PubMed ID: 22305531; Belet et al. 2014. PubMed ID: 24357517).
Genetics
Multiple congenital anomalies-hypotonia-seizures syndrome 2 is inherited in an X-linked recessive manner and caused by pathogenic variants in the PIGA gene which encodes the phosphatidylinositol glycan anchor biosynthesis class A protein. This protein is one of the enzymes involved in the first step of biosynthesis of the glycosylphosphatidylinositol (GPI) anchor, a glycolipid structure embedded in the plasma membrane. PIGA pathogenic variants are one genetic cause of early onset epileptic encephalopathy. Pathogenic variants in PIGA gene include missense, nonsense, splicing, and small deletion/duplications (both frameshift and in-frame). No large deletions and duplications have been reported (Johnston et al. 2012. PubMed ID: 22305531; Kato et al. 2014. PubMed ID: 24706016; Tarailo-Graovac et al. 2015. PubMed ID: 25885527; Human Gene Mutation Database).
Clinical Sensitivity - Sanger Sequencing
Clinical sensitivity of PIGA in a large cohort of patients with Multiple congenital anomalies-hypotonia-seizures syndrome 2 relevant phenotypes is unavailable in the literature, because most of the studies are case reports. Analytical sensitivity is expected to be high because the pathogenic variants reported should be detectable by sequencing. PIGA pathogenic variants appear to be a rare cause of disease.
No large deletions and duplications have been reported involving the PIGA gene (Johnston et al. 2012. PubMed ID: 22305531; Kato et al. 2014. PubMed ID: 24706016; Tarailo-Graovac et al. 2015. PubMed ID: 25885527; Human Gene Mutation Database).
Testing Strategy
This test involves bidirectional Sanger sequencing of all coding exons and splice sites of the PIGA gene. The full coding sequence of each exon plus ~10 bp of flanking DNA on either side are sequenced. We will also sequence any single exon (Test #100) or pair of exons (Test #200) in family members of patients with known mutations or to confirm research results.
Indications for Test
PIGA sequencing is recommended for patients who are suspected to have Multiple congenital anomalies-hypotonia-seizures syndrome 2.
PIGA sequencing is recommended for patients who are suspected to have Multiple congenital anomalies-hypotonia-seizures syndrome 2.
Gene
Official Gene Symbol | OMIM ID |
---|---|
PIGA | 311770 |
Inheritance | Abbreviation |
---|---|
Autosomal Dominant | AD |
Autosomal Recessive | AR |
X-Linked | XL |
Mitochondrial | MT |
Diseases
Name | Inheritance | OMIM ID |
---|---|---|
Multiple Congenital Anomalies-Hypotonia-Seizures Syndrome 2 | XL | 300868 |
Paroxysmal Nocturnal Hemoglobinuria | XL | 300818 |
Citations
Ordering/Specimens
Ordering Options
We offer several options when ordering sequencing tests. For more information on these options, see our Ordering Instructions page. To view available options, click on the Order Options button within the test description.
myPrevent - Online Ordering
- The test can be added to your online orders in the Summary and Pricing section.
- Once the test has been added log in to myPrevent to fill out an online requisition form.
- PGnome sequencing panels can be ordered via the myPrevent portal only at this time.
Requisition Form
- A completed requisition form must accompany all specimens.
- Billing information along with specimen and shipping instructions are within the requisition form.
- All testing must be ordered by a qualified healthcare provider.
For Requisition Forms, visit our Forms page
Specimen Types
ORDER OPTIONS
View Ordering Instructions1) Select Test Type
2) Select Additional Test Options
No Additional Test Options are available for this test.